AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan

[1]  Xiangmei Zhou,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[2]  A. Salminen,et al.  Control of p53 and NF-κB signaling by WIP1 and MIF: role in cellular senescence and organismal aging. , 2011, Cellular signalling.

[3]  T. Horng,et al.  Linking the inflammasome to obesity-related disease , 2011, Nature Medicine.

[4]  B. Viollet,et al.  Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.

[5]  C. Apovian,et al.  Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. , 2011, Biochemical and biophysical research communications.

[6]  B. Gabryel,et al.  Metformin reduces the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures , 2011 .

[7]  C. Bernstein,et al.  AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. , 2010, Biochemical pharmacology.

[8]  D. Herranz,et al.  SIRT1: recent lessons from mouse models , 2010, Nature Reviews Cancer.

[9]  Stephen F. Lowry,et al.  Roles of SIRT1 in the Acute and Restorative Phases following Induction of Inflammation* , 2010, The Journal of Biological Chemistry.

[10]  A. Levine,et al.  p53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Sarah Hummasti,et al.  Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes , 2010, Circulation research.

[12]  Hongwei Yao,et al.  Regulation of SIRT1 in cellular functions: role of polyphenols. , 2010, Archives of biochemistry and biophysics.

[13]  J. Auwerx,et al.  Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility , 2010, Oncogene.

[14]  Jun Ren,et al.  AMP‐activated protein kinase deficiency exacerbates aging‐induced myocardial contractile dysfunction , 2010, Aging cell.

[15]  T. Chan,et al.  The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. , 2010, Cardiovascular research.

[16]  Qing Xu,et al.  Myeloid Deletion of SIRT1 Induces Inflammatory Signaling in Response to Environmental Stress , 2010, Molecular and Cellular Biology.

[17]  B. Aggarwal.  Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. , 2010, Annual review of nutrition.

[18]  J. Auwerx,et al.  AMP-activated protein kinase and its downstream transcriptional pathways , 2010, Cellular and Molecular Life Sciences.

[19]  A. Salminen,et al.  Genetics vs. entropy: Longevity factors suppress the NF-κB-driven entropic aging process , 2010, Ageing Research Reviews.

[20]  Simon C Watkins,et al.  AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells. , 2010, American journal of respiratory cell and molecular biology.

[21]  I. Ben-Sahra,et al.  Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? , 2010, Molecular Cancer Therapeutics.

[22]  B. Gustafson.  Adipose tissue, inflammation and atherosclerosis. , 2010, Journal of atherosclerosis and thrombosis.

[23]  Zhenggang Yang,et al.  Macrophage α1 AMP-activated Protein Kinase (α1AMPK) Antagonizes Fatty Acid-induced Inflammation through SIRT1* , 2010, The Journal of Biological Chemistry.

[24]  B. Kemp,et al.  5‐aminoimidazole‐4‐carboxamide ribonucleoside and AMP‐activated protein kinase inhibit signalling through NF‐κB , 2010, Immunology and cell biology.

[25]  B. Viollet,et al.  AMPK&agr;2 Deletion Causes Aberrant Expression and Activation of NAD(P)H Oxidase and Consequent Endothelial Dysfunction In Vivo: Role of 26S Proteasomes , 2010, Circulation research.

[26]  N. Ruderman,et al.  AMPK and SIRT1: a long-standing partnership? , 2010, American journal of physiology. Endocrinology and metabolism.

[27]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[28]  Mingyuan Wu,et al.  Activation of AMP-Activated Protein Kinase Inhibits Oxidized LDL-Triggered Endoplasmic Reticulum Stress In Vivo , 2010, Diabetes.

[29]  Qilong Wang,et al.  Activation of AMP-activated Protein Kinase α1 Alleviates Endothelial Cell Apoptosis by Increasing the Expression of Anti-apoptotic Proteins Bcl-2 and Survivin* , 2010, The Journal of Biological Chemistry.

[30]  Mengwei Zang,et al.  AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. , 2010, Future oncology.

[31]  D. Hardie,et al.  Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. , 2010, Biochimica et biophysica acta.

[32]  H. Choi,et al.  Reduction of AMP-Activated Protein Kinase α2 Increases Endoplasmic Reticulum Stress and Atherosclerosis In Vivo , 2010 .

[33]  E. Tajkhorshid,et al.  Functional Interplay between Acetylation and Methylation of the RelA Subunit of NF-κB , 2010, Molecular and Cellular Biology.

[34]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[35]  L. Velloso,et al.  The role of proliferator-activated receptor gamma coactivator-1alpha in the fatty-acid-dependent transcriptional control of interleukin-10 in hepatic cells of rodents. , 2010, Metabolism: clinical and experimental.

[36]  M. Korbonits,et al.  AMPK as a mediator of hormonal signalling. , 2010, Journal of molecular endocrinology.

[37]  E. Maury,et al.  Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome , 2010, Molecular and Cellular Endocrinology.

[38]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[39]  B. Gabryel,et al.  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures. , 2010, Neurotoxicology.

[40]  T. Suuronen,et al.  ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology , 2009, Journal of Neuroinflammation.

[41]  Janet M. Thornton,et al.  Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span , 2009, Science.

[42]  R. DePinho,et al.  FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. , 2009, Gastroenterology.

[43]  Jin-Taek Hwang,et al.  AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. , 2009, New biotechnology.

[44]  Kevin M. Ryan,et al.  p53 and metabolism , 2009, Nature Reviews Cancer.

[45]  A. Salminen,et al.  SIRT1: regulation of longevity via autophagy. , 2009, Cellular signalling.

[46]  K. E. Jones,et al.  Nutrient Stress Activates Inflammation and Reduces Glucose Metabolism by Suppressing AMP-Activated Protein Kinase in the Heart , 2009, Diabetes.

[47]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[48]  B. Fisslthaler,et al.  Activation and signaling by the AMP-activated protein kinase in endothelial cells. , 2009, Circulation research.

[49]  J. Coselli,et al.  Activation of the AMPK-FOXO3 Pathway Reduces Fatty Acid–Induced Increase in Intracellular Reactive Oxygen Species by Upregulating Thioredoxin , 2009, Diabetes.

[50]  B. Kemp,et al.  AMPK in Health and Disease. , 2009, Physiological reviews.

[51]  Gaochao Zhou,et al.  AMPK: an emerging drug target for diabetes and the metabolic syndrome. , 2009, Cell metabolism.

[52]  G. Zhou,et al.  AMPK activators – potential therapeutics for metabolic and other diseases , 2009, Acta physiologica.

[53]  T. Hupp,et al.  The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway , 2009, Aging.

[54]  A. Salminen,et al.  Regulation of the aging process by autophagy. , 2009, Trends in molecular medicine.

[55]  A. Salminen,et al.  NF-κB Signaling in the Aging Process , 2009, Journal of Clinical Immunology.

[56]  J. Mandl,et al.  Endoplasmic Reticulum: Nutrient Sensor in Physiology and Pathology , 2022 .

[57]  P. Puigserver,et al.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity , 2009, Nature.

[58]  João Pedro de Magalhães,et al.  Meta-analysis of age-related gene expression profiles identifies common signatures of aging , 2009, Bioinform..

[59]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[60]  F. Martinon,et al.  The inflammasomes: guardians of the body. , 2009, Annual review of immunology.

[61]  J. Petrie,et al.  AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease , 2009, Clinical science.

[62]  N. Tanaka,et al.  Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification , 2009, Proceedings of the National Academy of Sciences.

[63]  T. Chan,et al.  TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. , 2009, Cardiovascular research.

[64]  Yitao Wang,et al.  Adiponectin, an unlocking adipocytokine. , 2009, Cardiovascular therapeutics.

[65]  N. Ruderman,et al.  AMPK and the biochemistry of exercise: implications for human health and disease. , 2009, The Biochemical journal.

[66]  R. Roy,et al.  Caenorhabditis elegans dauers need LKB1/AMPK to ration lipid reserves and ensure long-term survival , 2009, Nature.

[67]  M. Freichel,et al.  Ca2+ Entry via TRPC Channels Is Necessary for Thrombin-induced NF-κB Activation in Endothelial Cells through AMP-activated Protein Kinase and Protein Kinase Cδ* , 2009, Journal of Biological Chemistry.

[68]  T. Chan,et al.  TNF- a reduces PGC-1 a expression through NF- k B and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model , 2009 .

[69]  J. Suttles,et al.  Adenosine 5′-Monophosphate-Activated Protein Kinase Promotes Macrophage Polarization to an Anti-Inflammatory Functional Phenotype1 , 2008, The Journal of Immunology.

[70]  A. Vidal-Puig,et al.  AMPK: a metabolic gauge regulating whole-body energy homeostasis. , 2008, Trends in molecular medicine.

[71]  G. Hotamisligil,et al.  Nutrient sensing and inflammation in metabolic diseases , 2008, Nature Reviews Immunology.

[72]  B. Viollet,et al.  Upregulation of Mitochondrial Uncoupling Protein-2 by the AMP-Activated Protein Kinase in Endothelial Cells Attenuates Oxidative Stress in Diabetes , 2008, Diabetes.

[73]  N. Ruderman,et al.  SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1 , 2008, Journal of Biological Chemistry.

[74]  T. Suuronen,et al.  SIRT1 longevity factor suppresses NF‐κB ‐driven immune responses: regulation of aging via NF‐κB acetylation? , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[75]  E. Abraham,et al.  Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. , 2008, American Journal of Physiology - Lung cellular and Molecular Physiology.

[76]  G. López-Lluch,et al.  Mitochondrial biogenesis and healthy aging , 2008, Experimental Gerontology.

[77]  Randal J. Kaufman,et al.  From endoplasmic-reticulum stress to the inflammatory response , 2008, Nature.

[78]  Y. Hattori,et al.  High molecular weight adiponectin activates AMPK and suppresses cytokine‐induced NF‐κB activation in vascular endothelial cells , 2008, FEBS letters.

[79]  Nobuyuki Tanaka,et al.  p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation , 2008, Nature Cell Biology.

[80]  S. Peng,et al.  Foxo in the immune system , 2008, Oncogene.

[81]  T. Suuronen,et al.  Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging , 2008, Ageing Research Reviews.

[82]  S. Amar,et al.  Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model. , 2008, Atherosclerosis.

[83]  J. Nakae,et al.  The FoxO transcription factors and metabolic regulation , 2008, FEBS letters.

[84]  Eran Segal,et al.  Motif module map reveals enforcement of aging by continual NF-κB activity , 2007 .

[85]  B. Goldstein,et al.  Adiponectin suppresses IκB kinase activation induced by tumor necrosis factor-α or high glucose in endothelial cells: role of cAMP and AMP kinase signaling , 2007 .

[86]  S. Gygi,et al.  The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor* , 2007, Journal of Biological Chemistry.

[87]  S. Gygi,et al.  An AMPK-FOXO Pathway Mediates Longevity Induced by a Novel Method of Dietary Restriction in C. elegans , 2007, Current Biology.

[88]  D. Das,et al.  Anti-inflammatory responses of resveratrol. , 2007, Inflammation & allergy drug targets.

[89]  Zhang Pengju,et al.  Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKα , 2007, Experimental & Molecular Medicine.

[90]  Miao Zhang,et al.  Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.

[91]  D. Befroy,et al.  Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis , 2007, Cell metabolism.

[92]  I. Rahman,et al.  Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[93]  D. Akbar.  Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome , 2003, Endocrine.

[94]  Hyoung-Tae Kim,et al.  Effects of PGC-1α on TNF-α–Induced MCP-1 and VCAM-1 Expression and NF-κB Activation in Human Aortic Smooth Muscle and Endothelial Cells , 2006 .

[95]  J. Shyy,et al.  Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo , 2006, Circulation.

[96]  David Carling,et al.  Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. , 2006, Cell metabolism.

[97]  P. Puigserver,et al.  Resveratrol improves health and survival of mice on a high-calorie diet , 2006, Nature.

[98]  Kunihiro Suzuki,et al.  Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells , 2006, Hypertension.

[99]  P. Distefano,et al.  Aging networks in Caenorhabditis elegans: AMP‐activated protein kinase (aak‐2) links multiple aging and metabolism pathways , 2006, Aging cell.

[100]  M. Hori,et al.  AMP-Activated Protein Kinase Protects Cardiomyocytes against Hypoxic Injury through Attenuation of Endoplasmic Reticulum Stress , 2005, Molecular and Cellular Biology.

[101]  C. Chen,et al.  SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. , 2005, International journal of molecular medicine.

[102]  Shailendra Giri,et al.  5-Aminoimidazole-4-Carboxamide Ribonucleoside: A Novel Immunomodulator with Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[103]  M. Brennan,et al.  p53 is a suppressor of inflammatory response in mice , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  Russell G. Jones,et al.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. , 2005, Molecular cell.

[105]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[106]  J. Keaney,et al.  AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. , 2004, Biochemical and biophysical research communications.

[107]  A. Aljada,et al.  Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. , 2004, The Journal of clinical endocrinology and metabolism.

[108]  Jonathan D. Hron,et al.  Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. , 2004, Immunity.

[109]  B. Pedersen,et al.  AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. , 2004, Biochemical and biophysical research communications.

[110]  Richard T. Lee,et al.  Hyperglycemia Promotes Oxidative Stress through Inhibition of Thioredoxin Function by Thioredoxin-interacting Protein* , 2004, Journal of Biological Chemistry.

[111]  M. Mayo,et al.  Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.

[112]  B. Viollet,et al.  5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein Kinase , 2004, The Journal of Neuroscience.

[113]  S. Hussain,et al.  Nitric oxide and p53 in cancer‐prone chronic inflammation and oxyradical overload disease , 2004, Environmental and molecular mutagenesis.

[114]  E. Kraegen,et al.  Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. , 2001, Biochemical Society transactions.

[115]  أ.د. دعـــد أكبر.  Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome , 2003 .

[116]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.

[117]  A. Yashin,et al.  The network and the remodeling theories of aging: historical background and new perspectives , 2000, Experimental Gerontology.

[118]  B. Ames,et al.  The free radical theory of aging matures. , 1998, Physiological reviews.